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A B S T R A C T
Background: We conducted blood culture surveillance to estimate the incidence of typhoid and
paratyphoid fever among urban slum residents in Dhaka, Bangladesh.
Methods: Between January 7, 2003 and January 6, 2004, participants were visited weekly to detect
febrile illnesses. Blood cultures were obtained at the clinic from patients with fever (38 8C). Salmonella
isolates were assayed for antimicrobial susceptibility.
Results: Forty Salmonella Typhi and eight Salmonella Paratyphi Awere isolated from 961 blood cultures.
The incidence of typhoid fever was 2.0 episodes/1000 person-years, with a higher incidence in children
aged < 5 years (10.5/1000 person-years) than in older persons (0.9/1000 person-years) (relative
risk = 12, 95% conﬁdence interval (CI) 6.3–22.6). The incidence of paratyphoid fever was 0.4/1000
person-years without variation by age group. Sixteen S. Typhi isolates were multidrug-resistant (MDR).
All S. Paratyphi isolates were pan-susceptible. The duration of fever among patients with an MDR S.
Typhi infection was longer than among patients with non-MDR S. Typhi (16  8 vs. 11  4 days, p = 0.02)
and S. Paratyphi (10  2 days, p = 0.04) infections.
Conclusions: Typhoid fever is more common than paratyphoid fever in the urban Bangladeshi slum;
children < 5 years old have the highest incidence. Multidrug resistance is common in S. Typhi isolates
and is associated with prolonged illness. Strategies for typhoid fever prevention in children aged < 5
years in Bangladesh, including immunization, are needed.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Typhoid fever occurred in more than 20 million people in the
year 2000 and causes approximately 200 000 deaths annually.1
More than 90% of typhoid fever cases are estimated to occur in Asia.
The challenges of reliably diagnosing typhoid fever have led to
varying estimates of the disease burden and epidemiology in Asia.
In India and Bangladesh, the highest incidence has been observed
among children aged <5 years, while in Vietnam, the peak
incidence has been found to occur in children aged 5–9 years.2–4
The recent increase in ﬂuoroquinolone resistance of Salmonella
enterica serotype Typhi has raised concerns due to the limited
treatment options available in typhoid endemic countries;5–8 as a
result, theWorld Health Organization (WHO) is beginning to focus
resources on the promotion of typhoid immunization for children
in endemic countries in Asia.9 Population-based incidence data are* Corresponding author. Tel.: +880 2 9881761; fax: +880 2 8823963.
E-mail address: anaheed@icddrb.org (A. Naheed).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.11.023helpful in identifying high-risk populations, regions, and age
groups for targeted vaccination programs for the prevention of
typhoid fever in resource-limited, developing countries.
Because the transmission of S. Typhi often involves factors such
as hygiene, water quality, and food handling, which impact
transmission of other enteric pathogens, additional information on
the disease burden of invasive non-Typhi Salmonella could provide
a basis for more aggressive programs to minimize transmission of
all Salmonella. An increase in the incidence of S. Paratyphi has been
reported from some Asian countries where typhoid fever is
endemic.10 Several Asian countries have reported the emergence of
ﬂuoroquinolone resistance among S. Paratyphi.11–17 The overall
situation has heightened the need to identify preventionmeasures,
including vaccines, against a variety of invasive enteric patho-
gens.10,18,19 However, a vaccine against paratyphoid fever is not yet
available, and immunization with currently available vaccines
against typhoid fever does not provide cross-protection against
paratyphoid fever.
In Bangladesh, no epidemiologic data on paratyphoid fever have
been available. We conducted blood culture surveillance in anses. Published by Elsevier Ltd. All rights reserved.
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estimate the incidence and determine the antimicrobial suscept-
ibility patterns of S. Typhi and S. Paratyphi. We also studied strain
heterogeneity of S. Typhi by pulsed-ﬁeld gel electrophoresis (PFGE)
subtyping to determine the extent of genetic variation among
drug-resistant strains.
2. Methods
2.1. Study sites
In 2000, the International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) established a surveillance system
in Kamalapur, a densely populated informal settlement in Dhaka,
for the purposes of conducting active fever surveillance on a
portion of the population. The area was divided into 377 clusters
for the convenience of surveillance, and 85 clusters were randomly
selected for this study. The 85 clusters included in the surveillance
were proportionally distributed across the entire study area and
were representative of the population residing in all 377 clusters.
All inhabitants of households within the selected clusters were
approached and enrolled following written consent; a household
was deﬁned as all persons that ate from the same cooking pot.
People moving into one of the 85 clusters at any point during the
study period were included in the surveillance. An individual’s
participation was terminated due to migration out of the cluster
under surveillance, death, or withdrawal of consent.
2.2. Active fever surveillance
During the study period, between January 7, 2003 and January
6, 2004, ﬁeld research workers conducted weekly visits to
participating households to obtain a history of fever during the
past 7 days. All participants who had consented to participate in
the surveillance had access to free medical care at the study clinic
(located within the surveillance area, 3 km from each participat-
ing household) and were offered free medical care there by eight
trained study physicians and eight nurses. Children aged <5 years
with a history of fever of any duration, and persons5 years of age
with fever of3 days duration, were referred to the study clinic for
clinical assessment by qualiﬁed study physicians. Study physicians
obtained blood for culture from the patients with a history of fever,
if the axillary temperature was 38 8C when assessed at the clinic.
2.3. Microbiology
Blood was collected aseptically at the study clinic, inoculated
into commercially available blood culture medium (Hemoline
performance diphasique, bioMe´rieux, France), and processed at the
ICDDR,B microbiology laboratory, as described elsewhere.20
Standard procedures were used to identify S. Typhi and S.
Paratyphi A and B. Antimicrobial susceptibility of the Salmonella
strains was assessed using disk diffusion according to the Clinical
and Laboratory Standards Institute (CLSI; formerly NCCLS) guide-
lines for the following agents: ampicillin, chloramphenicol,
trimethoprim–sulfamethoxazole, nalidixic acid, ciproﬂoxacin,
and ceftriaxone.21 The minimum inhibitory concentrations (MIC)
were measured using the Etest when an isolate was resistant to
one or more antibiotics tested (AB Biodisk, Solna, Sweden). An
isolate was deﬁned as multidrug-resistant (MDR) if resistance was
observed to all three ﬁrst-line antibiotics (chloramphenicol,
ampicillin, and trimethoprim–sulfamethoxazole). All other iso-
lates were labeled as non-MDR.
PFGE was performed on S. Typhi isolates at the ICDDR,B
laboratories following standard procedures.22,23 PFGE analysis of S.
Paratyphi isolates was not performed.2.4. Treatment
All febrile patients were clinically managed at the study clinic
according to a standardized treatment algorithm and had equal
opportunity for receiving free health care irrespective of severity of
illness or compliance with blood culture. Participants who
underwent blood culture were visited at their homes daily until
they were afebrile for 3 consecutive days. A clinical diagnosis of
typhoid fever was made for the following clinical presentations:
documented fever 38 8C (axillary) with a history of fever of any
duration in children < 5 years old or of at least 3 days for persons
5 years old, and without a focus of infection. Persons with
clinically diagnosed typhoid fever or other Salmonella infection
were treated with ampicillin or trimethoprim–sulfamethoxazole.
Ciproﬂoxacin and ceftriaxone were reserved for MDR infections. If
a patient’s condition worsened while on antibiotics or did not
improve clinically after 48 h of therapy, s/he was referred to the
ICDDR,B hospital for further management.
2.5. Data analysis
The incidences of typhoid and paratyphoid fever were
calculated by dividing the number of blood culture-conﬁrmed
episodes by the person-years of observation.24,25 The actual
number of days were added to calculate person-days of observa-
tion for each individual while s/he was under active surveillance,
and were divided by 365 days to calculate the person-years of
observation. We calculated the incidence of typhoid fever in two
ways. First, we calculated the incidence of typhoid fever among the
study population based on the febrile episodes when a blood
culture was obtained, in order to extrapolate the lowest possible
estimate of typhoid fever incidence in the study population.
Second, we assumed that the persons who did not provide a blood
culture would yield S. Typhi in blood culture at a similar rate as
those who did provide a blood culture. So we applied the observed
S. Typhi isolation rate to those who did not have a blood culture
and calculated additional S. Typhi cases in order to compute the
highest possible estimate of typhoid fever incidence among the
study population.
Continuous variables were reported as mean value  standard
deviation (SD) or median value and range, and were compared across
groups using unpaired sample t-tests or non-parametric tests.
Differences between groups with respect to categorical variables
were assessed using the Pearson Chi-square or Fisher’s exact test.
2.6. Ethical issues
Written informed consent was obtained from heads of
participating households on behalf of all household members at
the time of enrollment, before initiation of active surveillance; it
covered consent for weekly home visits, blood culture for persons
with a febrile episode, and collection of clinical data following
culture. Each individual participant had the right to withdraw her/
his consent at any time.
This study was approved by the Ethics Review Committee of
ICDDR,B and the Institutional Review Board of the Centers for
Disease Control and Prevention (CDC; Atlanta, GA, USA).
3. Results
During the study period, 26 583 persons were living in the
randomly selected clusters and total of 24 893 individuals (94%)
were enrolled from 5513 households in the active surveillance for
febrile illness; 1690 persons (6%) declined participation in the
surveillance. The mean age ( SD) of the population under
surveillance was 25 years ( 17) including 3520 children aged <5
Table 1
Features of patients who did and did not provide blood for culture among patients with fever in the active surveillance for Salmonella infection, Bangladesh, 2003–2004
(N=1148)
Main features Blood culture performed (n=863) Blood culture not performed (n=285) p-Value
Age, median (range) years 4.4 (0–82) 2.6 (0–70) <0.001
Children <5 years, n (%) 483 (56) 220 (77) <0.001
Male, n (%) 442 (51) 138 (48) 0.2
Clinical diagnosis of typhoid fever, n (%) 213 (25) 6 (2) <0.001
Axillary temperature, mean ( SD) 8C 38.9 ( 0.7) 39.9 ( 0.7) 0.5
SD, standard deviation.
Figure 1. Incidence of typhoid and paratyphoid fever by month, 2003–2004.
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surveillance project for 10 months ( 3). Among the enrolled
individuals, 20 765 persons (83%) lived in the surveillance area
throughout the entire study period; 2334 persons (9%) migrated into
the surveillance clusters, 1700 persons (7%) migrated out of the
surveillance clusters, 48 persons (0.2%) died, and 46 persons (0.2%)
withdrew consent before the study period ended. During 12 months
of surveillance, 19 710 person-years were observed, including 2381
person-years among children aged <5 years.
Study physicians identiﬁed 1333 fever episodes among 1148
persons visiting the study clinic in 12months (67.6 fever episodes/
1000 person-years), including 868 fever episodes (65%) in children
<5 years old. Physicians obtained 4 ml ( 0.4) of blood for culture
during 961 episodes (72%) from 863 persons (including 96 patients
with >1 fever episode). Of the samples collected for blood culture,
564 were from episodes in children aged <5 years (59%). Blood
culture could not be obtained for 372 fever episodes (28%) among 285
persons (25%), and 304 episodes (82%) were among children aged <5
years. The reasons for not obtaining a blood culture were: parent/
legal guardian did not approve a blood culture (n = 338, 91%), the legal
guardianwas not present to provide valid consent (n = 17, 5%), doctor
postponed blood culture due to lack of adequate supplies for culture
(n = 11, 3%), and information was not available for six (2%) episodes.
The patients from whom a culture was not obtained were younger in
age and were less likely to have a clinical diagnosis of typhoid fever
than those who had a blood culture (Table 1).
Of the 961 episodes, an antimicrobialwas reported to have been
taken in 91 (10%) before the blood specimen was collected. A
bacterial pathogen was isolated from 70 episodes yielding an
isolation rate of 7.3%. The bacterial isolation rate among the
personswhowere treatedwith an antimicrobial drug (n = 11) prior
to blood culture was not different than among those who were not
treated with an antimicrobial drug (n = 59) prior to blood culture
(12% vs. 7%; p = 0.09). S. Typhi was isolated from blood cultures of
40 episodes in 40 persons, yielding an isolation rate of 4.2%; 25
isolateswere yielded among children<5 years old (isolation rate of
4.4%). S. Paratyphi A was isolated from eight episodes in eight
persons (11%), including one child <5 years old (13%); no S.
Paratyphi B, S. Paratyphi C, or other Salmonella serotypes were
identiﬁed.
3.1. Incidence
S. Typhi was isolated fromblood cultures everymonth, with the
greatest number of cases occurring in April, August, and December
(Figure 1). The overall incidence of blood culture-conﬁrmed
typhoid fever was 2.0 episodes (95% conﬁdence interval (CI) 1.5–
2.8)/1000person-years. The incidence in children < 5years oldwas
10.5 episodes (95% CI 6.8–15.5)/1000 person-years, which was 12-
fold greater than the incidence among persons5 years of age (0.9
episodes (95% CI 0.5–1.4)/1000 person-years; relative risk
(RR) = 12, 95% CI 6.3–22.6). Among children < 5 years old, the
highest incidence was observed among children aged 12 months
(11.5 episodes (95%CI 7.3–17.2)/1000person-years). The incidenceof S. Paratyphi infection was 0.4 episodes (95% CI 0.2–0.8)/1000
person-years, and did not differ between children < 5 years old and
those aged 5 years old.
When we applied the overall isolation rate of S. Typhi (4.2%)
among the persons who did not have a blood culture (n = 372), we
detected an additional 15 (372  0.042) S. Typhi cases, and the
overall incidence of typhoid fever in the study population was
estimated to be 2.8 episodes/1000 person-years. With a similar
calculation, we detected an additional 13 (304  0.044) S. Typhi
cases among children aged < 5 years and three (68  0.038) S.
Typhi cases among persons 5 years old. Hence, the highest
incidence of typhoid fever was estimated to be 16.0 episodes/1000
person-years among children aged<5 years and 1.0 episodes/1000
person-years among those aged 5 years.
3.2. Antimicrobial susceptibility and PFGE patterns
Of the 40 S. Typhi isolates, 17 were resistant to trimethoprim–
sulfamethoxazole (43%), 17 to chloramphenicol (43%), 16 to
ampicillin (40%), and 16 to nalidixic acid (40%). Sixteen isolates
(40%) were resistant to all three ﬁrst-line antibiotics (MDR). Two
isolates (5%) had single resistance to nalidixic acid (NAR) and one
isolate (3%) was sensitive to ampicillin but resistant to trimetho-
prim–sulfamethoxazole, chloramphenicol, and nalidixic acid. Eight
of 40 S. Typhi isolates (20%) had reduced susceptibility to
ciproﬂoxacin (MIC 0.19–0.38mg/ml); ﬁve of them were MDR,
threewere non-MDR, and sevenwere NAR S. Typhi strains. All 40 S.
Typhi isolates were susceptible to ceftriaxone. Twenty-one S.
Typhi isolates (53%) and all eight S. Paratyphi isolates (100%) were
susceptible to all drugs tested.
PFGE analysis of 40 S. Typhi yielded 10 patterns; 20 (50%)
isolates belonged to a single type (homogeneous), and the
remaining 20 belonged to nine different types (heterogeneous).
Sixteen of 20 homogeneous isolates (80%) were MDR. Thirteen of
the 16MDR homogeneous isolates (81%) and three of the four non-
MDR homogeneous isolates were NAR strains. All 20 hetero-
Table 2
Comparison of demographic and clinical features of patients with typhoid and paratyphoid fever and patients with other febrile illness in active surveillance for Salmonella
infection, Bangladesh, 2003–2004
Clinical characteristics Salmonella Typhi (n=40) Salmonella Paratyphi A (n=8) Other febrile illness (n=913)a
Male 19 (48) 7 (88) 469 (51)
Children <5 years 25 (63) 1 (13)b 538 (59)c
Antibiotic taken at home 8 (20) 1 (3) 82 (9)b
Cough 22 (55) 2 (25) 678 (74)b,c
Runny nose 28 (70) 5 (63) 558 (61)
Vomiting 7 (18) 1 (13) 143 (16)
Headache 10 (25) 7 (88)b 364 (40)c
Myalgia 6 (15) 6 (75)b 290 (32)c
Tenesmus 8 (20) 0 74 (8)b
Constipation 1 (3) 2 (25) 63 (7)
Watery stool 10 (25) 0 105 (12)b
Bloody stool 2 (5) 0 16 (2)
Abdominal pain 10 (25) 2 (25) 161 (18)
Abdominal tenderness 1 (3) 0 16 (2)
Irritability 5 (13) 2 (25) 233 (26)
Loss of appetite 24 (60) 3 (38) 606 (66)
Hospitalization 4 (10) 0 13 (1)b
Duration of fever between onset and resolution, days 13 ( 7) 10 ( 2)b 7 ( 5)b,c
Results are n (%) or mean ( standard deviation).
a Eight Salmonella Paratyphi A cases were excluded from other febrile illness.
b p < 0.05 when compared to Salmonella Typhi.
c p < 0.05 when compared to Salmonella Paratyphi.
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all antimicrobial drugs tested.
3.3. Clinical features
Clinical manifestations of patients with typhoid fever were
generally similar to those of other febrile patientswho did not have
Salmonella bacteremia. However, the patients with S. Typhi
infections more frequently reported tenesmus, watery stool, and
required hospitalization, than the patients who did not have S.
Typhi infection (Table 2). At initial presentation to the clinic, the
duration of fever among patientswith S. Typhi infectionwas longer
than in the patients who did not have Salmonella infection (5  3
days vs. 4  3 days, p = 0.002). The patientswith S. Paratyphi infection
were older in age, more frequently reported headache and myalgia,
and became afebrile earlier than the patients with S. Typhi infection.
Tenesmus, watery stool, bloody stool, abdominal tenderness, and
hospitalization were not reported by any patients with S. Paratyphi
infection (Table 2). No deaths were reported among patients who had
presented with a febrile illness at the study clinic during the
surveillance period.
Among children <5 years old, children who had S. Typhi
infections had more frequently reported being treated with
antibiotics (n = 7, 28% vs. n = 40, 7%; p = 0.003), having watery stool
(n = 8, 32% vs. n = 71, 13%; p = 0.02), and requiring hospitalization
(n = 4, 16%, p = 0.002) than the children who did not have S. Typhi
infection.However, clinical features amongpersons5yearsolddid
not differ between those who had S. Typhi infection and those who
did not have S. Typhi infection (data not shown).
Clinical presentations among patients with S. Typhi infection
were not different between those aged<5 years and those aged5
years, except that children <5 years of age more frequently
reported a runny nose (60% vs. 20%; p = 0.02) and vomiting (28% vs.
0%; p = 0.03) than persons 5 years of age. On examination, ﬁve
children (20%) were less active or irritable, one had abdominal
tenderness (4%), and four required hospitalization (16%), which
were not reported among persons 5 years old.
3.4. Clinical response to antimicrobial therapy
Among 40 patients with S. Typhi infection, 26 recovered (65%)
with ﬁrst-line therapy (ampicillin or trimethoprim–sulfamethox-azole), 12 recovered (30%) with ciproﬂoxacin, and two recovered
(5%) with ceftriaxone. Among 24 patients infected with non-MDR
S. Typhi infection, 21 (88%) recovered after outpatient treatment
with ampicillin/trimethoprim–sulfamethoxazole; one patient (4%)
recovered without any antimicrobial treatment, two patients, both
children <5 years old, were hospitalized (8%); one hospitalized
child recovered with ampicillin and the other recovered with
ceftriaxone treatment in hospital. The three patients who had
reduced susceptibility to ciproﬂoxacin recovered after outpatient
treatment with trimethoprim–sulfamethoxazole.
Among 16 patients with MDR S. Typhi infection, 11 recovered
(69%) after outpatient treatment with ciproﬂoxacin, three recov-
ered (19%) after outpatient treatment with ampicillin/trimetho-
prim–sulfamethoxazole, and two, both children aged <5 years,
were hospitalized (12%); one hospitalized child recovered with
ciproﬂoxacin treatment and the other with ceftriaxone treatment.
All ﬁve patients who had reduced susceptibility to ciproﬂoxacin
recovered after treatment with ciproﬂoxacin, including the one
who required hospitalization. All patients infected with S.
Paratyphi recovered after outpatient treatment with a ﬁrst-line
agent without developing any complication.
The clinical features between patients with MDR S. Typhi
infection and non-MDR S. Typhi infection were generally similar at
initial presentation, except that patients with MDR S. Typhi
infection were more frequently treated with antibiotics before
coming to the study clinic and had a longer total duration of fever
(Table 3). However, the overall duration of the febrile episode
among the patientswith anMDR S. Typhi infectionwas longer than
that of the patients who had a non-MDR S. Typhi infection (16  8
days vs. 11  4 days, p = 0.02) despite treatment with antimicrobial
drugs. Although not statistically signiﬁcant at the 0.05 level, there
was a difference in illness duration following treatment between the
patients infectedwith NAR S. Typhi strains and patients infectedwith
non-NAR S. Typhi strains (15  8 days vs.11  5 days; p = 0.06).
4. Discussion
The incidence of invasive salmonellosis was found to be high
among the residents of the densely populated urban slum
community in Dhaka. S. Typhi bacteremia represents the bulk of
these cases, and S. Paratyphi A bacteremia represents the
remainder. The incidence of acute typhoid fever was higher
Table 3
Comparison of clinical features of patients with non-MDR and MDR Salmonella Typhi infection, 2003–2004
Clinical features Patients with non-MDR
Salmonella Typhi (n=24)
Patients with MDR
Salmonella Typhi (n=16)
p-Value
Children <5 years 17 (71) 8 (50) 0.2
Male 11 (46) 8 (50) 0.8
Antibiotic taken before culture 2 (8) 6 (38) 0.04
Duration of fever at the time of sample collection, days 4 ( 2) 6 ( 4) 0.05
Body temperature, 8C 39 ( 1) 39 ( 1) 0.9
Cough 13 (54) 9 (56) 0.8
Runny nose 11 (46) 7 (44) 0.9
Vomiting 4 (17) 3 (19) 0.9
Headache 6 (25) 4 (25) 0.7
Myalgia 4 (17) 2 (13) 0.6
Tenesmus 3 (13) 5 (31) 0.1
Constipation 1 (4) 0 0.4
Watery stool 4 (17) 6 (38) 0.1
Bloody stool 2 (8) 6 (38) 0.3
Abdominal pain 4 (17) 6 (38) 0.3
Abdominal tenderness 0 15 (94) 0.3
Irritability 4 (17) 1 (6) 0.3
Loss of appetite 16 (67) 8 (50) 0.3
Total duration of fever between illness onset and resolution, daysa 11 ( 4) 16 ( 8) 0.02
Hospitalization 2 (8) 2 (13) 0.6
Results are n (%) or mean ( standard deviation). MDR, multidrug-resistant.
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as we noted in a previous study conducted in the same
population.3 Infection with MDR S. Typhi resulted in a longer
duration of illness episodes despite treatment with antimicrobial
drugs to which the isolate was susceptible, as has been observed in
other studies.26,27 Multidrug and nalidixic acid resistance add to
the burden of typhoid fever and to the urgency of prevention
efforts.
While the incidence of invasive paratyphoid illness was
considerably lower, its documentation adds to the burden of
disease that could be prevented with effective programs aimed at
improving hygiene, sanitation, and water quality. The previous
study conducted in 2001 in the same study location of Kamalapur3
found a nearly two-fold higher incidence of S. Typhi bacteremia
compared to the incidence described here (3.9 episodes/1000
person-years vs. 2.0 episodes/1000 person-years). The opposite
trend was seen with the incidence of paratyphoid fever, which
nearly doubled from 2001 to the present (0.2 episodes/1000
person-years vs. 0.4 episodes per 1000 person-years; RR = 0.7, 95%
CI 0.3–1.8). Despite recent increases in S. Paratyphi A infection in a
few countries in Asia, S. Typhi infection remained the more
common of the two in our study setting, as has been observed in
other urban settings in India and Pakistan.28,29 In the present study
children aged <5 years more frequently suffered from typhoid
fever than paratyphoid fever, and, on average, typhoid fever caused
more severe illness among children <5 years old than persons 5
years old. Thus interventions thatwould reach those aged<5 years
are important in order to reduce the overall disease burden.
Resistance to nalidixic acid among S. Paratyphi isolates was
recently found to be more common than among S. Typhi isolates
obtained from hospitalized patients in India and Nepal, while MDR
was relatively rare among both pathogens.15–17 In contrast, all S.
Paratyphi A isolates identiﬁed in this study were susceptible to all
antimicrobial agents tested, while 40% of S. Typhi isolates were
MDR. This study further observed an association between MDR S.
Typhi strains and prior antibiotic use, which has been demon-
strated previously with other Gram-negative enteric pathogens.30–
32 In settings such as Kamalapurwhere over-the-counter antibiotic
use is common, it is possible that persons who report prior use of
antibiotics and are infected with non-MDR strains would not show
evidence of S. Typhi infection on blood culture. In contrast,
individualswho report prior use of antibiotics but are infectedwithan MDR strain would yield S. Typhi on blood culture. The PFGE
types of all MDR S. Typhi strains were similar, as has been
previously shown in studies from Bangladesh, Pakistan, Vietnam,
and Hong Kong.33–36 Although we did not observe treatment
failure with ciproﬂoxacin, two recent reports from Bangladesh
noted full resistance of MDR NAR S. Typhi strains to ciproﬂox-
acin.37,38 These developments underscore the importance of
monitoring antimicrobial susceptibility patterns, reviewing
options for guiding empirical therapy for typhoid fever, and
expanding efforts to prevent infection.
Similar to earlier studies, we also found that S. Typhi and S.
Paratyphi infections were not distinguishable clinically.39,40
However, several patients with S. Typhi infection required
hospitalization despite antimicrobial therapy guided by blood
culture, which was not observed for the patients with S. Paratyphi
infection. We did not document the occurrence of invasive non-
typhoidal Salmonella (such as Salmonella Enteriditis and Salmo-
nella Typhimurium) disease, which was consistent with other
studies in South Asia,3,17 but contrasted with the high incidence of
non-typhoidal Salmonella demonstrated in Africa.41,42 These
ﬁndings highlight the potential signiﬁcance of geographic location
for deﬁning and addressing the burden of invasive Salmonella
disease. Since food and water are primary vehicles for Salmonella
transmission, access to safe water, use of soap for hand washing,
and safe food handling practices would likely substantially reduce
the disease burden of Salmonella diseases and beneﬁt the entire
population.43–49
This study had several limitations. First, we relied on blood
culture for the diagnosis of typhoid fever. Blood culture is only 50–
80% sensitive and, thus, we may have underestimated the
incidence of typhoid fever by not capturing true cases.50–52
Second,wewere unable to obtain blood cultures from about a third
of the febrile episodes, primarily in very young children, a group in
whom typhoid fever incidence is high in Bangladesh and
elsewhere.2 We demonstrated that the incidence of typhoid fever
would have been higher at 16 episodes per 1000 person-years,
rather than our observed incidence of 11 episodes per 1000
person-years. Third, we identiﬁed ill patients via an active
population-based surveillance system and, hence, we likely
detected and treated patients earlier than they might have been
detected and treated in routine clinical care settings. Thismay have
led us to detect more cases of Salmonella bacteremia that are only
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facility-based passive surveillance approach. Earlier detection and
the resulting earlier clinical intervention may have helped avert
more severe illness and death, again leading to underestimation of
disease burden. Fourth, this study detected a limited number of S.
Typhi and S. Paratyphi isolates. Because of this, we had limited
power to fully compare the clinical characteristics of patients with
S. Typhi, S. Paratyphi, and other febrile illnesses. However, even
with a small sample size we identiﬁed signiﬁcant differences in
some clinical characteristics across the three groups. Despite these
limitations, we conﬁrmed a continuing high incidence of typhoid
fever in this population. Our ﬁndings underscore the importance of
prevention of typhoid fever in urban Bangladesh and in similar
settings.
We conclude that typhoid fever is endemic in an urban setting
in Bangladesh, resulting in signiﬁcant illness among pre-school
children. Paratyphoid fever, while occurring less frequently, may
increasingly contribute to the overall disease burden. As low
income workers are increasingly attracted to urban centers with
available jobs, the population residing in informal settlements
such as Kamalapur will continue to overwhelm the available water
and sanitary infrastructure. Targeted vaccination against S. Typhi
would be a valuable immediate step to reduce disease burden,
especially in urban Bangladeshi slums. The incidence of S.
Paratyphi demonstrates the need for longer term investment in
improved water and sanitation services to reduce the burden of
multiple fecal–oral transmitted pathogens in these communities.
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